Covid-19 roundup: Man­u­fac­tur­ing con­tract axed for Val­ne­va’s vac­cine; Pen­ny stock halts ear­ly in­fec­tion tri­al

French vac­cine com­pa­ny Val­ne­va and Ger­man CD­MO IDT Bi­ologi­ka have de­cid­ed to ter­mi­nate their man­u­fac­tur­ing col­lab­o­ra­tion for Val­ne­va’s Covid-19 vac­cine.

IDT Bi­ologi­ka was orig­i­nal­ly tasked with mak­ing Val­ne­va’s VLA2001 vac­cine, but the deal has been halt­ed due to “the de­liv­ery of in­ac­ti­vat­ed Covid-19 bulk vac­cine to Val­ne­va.” A state­ment from Val­ne­va al­so lists a lack of or­ders and suf­fi­cient in­ven­to­ry as the oth­er rea­sons.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER